ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995

IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators

May 21, 1993

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

Study: Partial Kidney Removal Leads to Greater Survival

March 29, 2013

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009